Zealand Pharma A/S
OTC:ZLDPF

Watchlist Manager
Zealand Pharma A/S Logo
Zealand Pharma A/S
OTC:ZLDPF
Watchlist
Price: 65.284 USD Market Closed
Market Cap: 4.6B USD

Wall Street
Price Targets

ZLDPF Price Targets Summary
Zealand Pharma A/S

Wall Street analysts forecast ZLDPF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZLDPF is 111.29 USD with a low forecast of 62.512 USD and a high forecast of 181.966 USD.

Lowest
Price Target
62.512 USD
4% Downside
Average
Price Target
111.29 USD
70% Upside
Highest
Price Target
181.966 USD
179% Upside
Zealand Pharma A/S Competitors:
Price Targets
BONEX
Bonesupport Holding AB
92% Upside
CBIO
Crescent Biopharma Inc (Pre-Reincorporation)
100% Upside
VYGR
Voyager Therapeutics Inc
307% Upside
TLX
Telix Pharmaceuticals Ltd
128% Upside
MRNA
Moderna Inc
10% Downside
CRNX
Crinetics Pharmaceuticals Inc
53% Upside
ELDN
Eledon Pharmaceuticals Inc
285% Upside
PASG
Passage Bio Inc
214% Upside

Revenue
Forecast

Revenue Estimate
Zealand Pharma A/S

For the last 13 years the compound annual growth rate for Zealand Pharma A/S's revenue is -6%. The projected CAGR for the next 4 years is 154%.

-6%
Past Growth
154%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Zealand Pharma A/S

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZLDPF's stock price target?
Price Target
111.29 USD

According to Wall Street analysts, the average 1-year price target for ZLDPF is 111.29 USD with a low forecast of 62.512 USD and a high forecast of 181.966 USD.

What is Zealand Pharma A/S's Revenue forecast?
Projected CAGR
154%

For the last 13 years the compound annual growth rate for Zealand Pharma A/S's revenue is -6%. The projected CAGR for the next 4 years is 154%.

Back to Top